- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-755/21: Order of the General Court of 13 January 2025 – Illumina v Commission (Competition – Concentrations – Pharmaceutical industry market – Genetic sequencing systems – Acquisition by Illumina of sole control over Grail – Decision imposing interim measures pursuant to Article 8(5)(a) of Regulation (EC) No 139/2004 – Withdrawal of the contested act – Disappearance of the subject matter of the action – No need to adjudicate)
ECLI:EU:UNKNOWN:62021TB0755
62021TB0755
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
Official Journal of the European Union
C series
—
C/2025/1883
(Case T-755/21)
(Competition - Concentrations - Pharmaceutical industry market - Genetic sequencing systems - Acquisition by Illumina of sole control over Grail - Decision imposing interim measures pursuant to Article 8(5)(a) of Regulation (EC) No 139/2004 - Withdrawal of the contested act - Disappearance of the subject matter of the action - No need to adjudicate)
(C/2025/1883)
Language of the case: English
Parties
Applicant: Illumina, Inc. (Wilmington, Delaware, United States) (represented by: D. Beard, Barrister-at-Law, and by P. Chappatte, F. González Díaz and M. Siragusa, lawyers)
Defendant: European Commission (represented by: P. Berghe, G. Conte and B. Ernst, acting as Agents)
Re:
By its action based on Article 263 TFEU, the applicant seeks the annulment of Commission Decision C(2021) 7675 final of 29 October 2021 to adopt interim measures (Case M.10493 – Illumina/Grail) pursuant to Article 8(5)(a) of Council Regulation (EC) No 139/2004 of 20 January 2004 on the control of concentrations between undertakings (OJ 2004 L 24, p. 1).
Operative part of the order
1.There is no longer any need to adjudicate on the action.
2.The European Commission shall bear its own costs and shall pay those incurred by Illumina, Inc.
—
(1) OJ C 37, 24.1.2022.
ELI: http://data.europa.eu/eli/C/2025/1883/oj
ISSN 1977-091X (electronic edition)
—